A STUDY OF CIS-PLATINUM AND IFOSFAMIDE IN ALKYLATING AGENT-RESISTANT OVARIAN-CANCER

被引：15

作者：

GREEN, JA ^{[1
]}

SLATER, AJ ^{[1
]}

机构：

[1] CLATTERBRIDGE HOSP,MERSEY REG CTR RADIOTHERAPY & ONCOL,MERSEYSIDE L63 4JY,ENGLAND

来源：

GYNECOLOGIC ONCOLOGY | 1989年 / 32卷 / 02期

关键词：

D O I：

10.1016/S0090-8258(89)80039-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：233 / 235

页数：3

共 12 条

[1]

BARKER GH, 1983, CHEMOTHERAPY GYNAECO

[2]

BLACKEDGE G, 1986, J CANCER RES CLIN, V3, P432

[3]

BRAHL P, 1976, INT J CLIN PHARM TH, V14, P29

[4]

BURKERT H, 1982, SEMIN ONCOL, V9, P28

[5] CONTROVERSY OVER COMBINATION CHEMOTHERAPY IN ADVANCED OVARIAN-CANCER - WHAT WE LEARN FROM REPORTS OF MATURED DATA [J].

DEMBO, AJ .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (11) :1573-1576

[6] PREDICTION OF IFOSFAMIDE MESNA ASSOCIATED ENCEPHALOPATHY [J].

MEANWELL, CA ;

BLAKE, AE ;

KELLY, KA ;

HONIGSBERGER, L ;

BLACKLEDGE, G .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (07) :815-819

[7]

NEIJT JP, 1983, CHEMIOTERAPIA, V2, P163

[8] THE CASE FOR COMBINATION CHEMOTHERAPY IN THE TREATMENT OF ADVANCED OVARIAN-CANCER [J].

OZOLS, RF .

JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (11) :1445-1447

[9]

PIVER MS, J SURG ONCOL, V24, P329

[10] CIS-PLATINUM IN THE TREATMENT OF ADVANCED OR RECURRENT ADENOCARCINOMA OF THE OVARY - A PHASE-II STUDY OF THE GYNECOLOGIC-ONCOLOGY-GROUP [J].

THIGPEN, JT ;

LAGASSE, L ;

HOMESLEY, H ;

BLESSING, JA .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1983, 6 (04) :431-435

← 1 2 →